ADA Says All Diabetes Patients Should Be Screened for Nonalcoholic ... - STAT
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
PubMed • GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Lean patients, differential diagnosis: as per AGA 2022 guidelines, exclude other causes of liver disease, including other causes of fatty liver, such as HIV, lipodystrophy, lysosomal acid lipase deficiency, familial hypobetalipoproteinemia, and medication-induced hepatic steatosis (methotrexate, amiodarone, tamoxifen, and steroids), in patients wit... See more
As devastating as it is, cirrhosis is not the only end point I’m worried about here. I care about NAFLD and NASH—and you should too—because they represent the tip of the iceberg of a global epidemic of metabolic disorders, ranging from insulin resistance to type 2 diabetes. Type 2 diabetes is technically a distinct disease, defined very clearly by
... See morePeter Attia MD • Outlive: The Science and Art of Longevity
New research shows that in humans, allulose has a favorable impact on blood glucose and may improve insulin sensitivity.